Physician profile
Carlos E Martinez
NPI 1710093083
$64,784.06
in general payments reported to CMS, 2019-2025
34 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $8,487 · 2021: $7,946 · 2022: $2,136 · 2023: $2,736 · 2024: $5,857 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $6,524 · Travel and Lodging: $2,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,200.00 |
| Food and Beverage | $6,523.80 |
| Travel and Lodging | $2,197.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25,436.33 | 2019-2022 | |
| Alcon Vision LLC | $12,273.38 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $9,166.05 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Research LLC | $7,058.55 | 2021-2024 | Lensx |
| Glaukos Corporation | $3,776.24 | 2019-2024 | Idose |
| Samsara Vision | $1,244.94 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $801.66 | 2019-2020 | |
| Sight Sciences, INC. | $756.76 | 2019-2025 | Omni Surgical System, Tearcare System |
| Abbvie INC. | $654.68 | 2022-2025 | |
| Carl Zeiss Meditec USA, INC. | $604.26 | 2021-2024 | Quatera 700, Iolmaster 700, Lumera 700 |
| Sun Pharmaceutical Industries INC. | $362.76 | 2019-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $262.40 | 2019-2021 | |
| Horizon Therapeutics Plc | $235.38 | 2021-2023 | Tepezza |
| Rxsight INC | $232.49 | 2020-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $217.25 | 2020-2025 | Tecnis Simplicity, Baerveldt Glaucoma Implant (250) |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $198.86 | 2021 | |
| Oyster Point Pharma, INC. | $197.43 | 2023-2025 | Tyrvaya |
| New World Medical,INC. | $178.73 | 2023-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Novartis Pharmaceuticals Corporation | $177.98 | 2019-2023 | |
| Carl Zeiss Meditec, INC. | $134.25 | 2019-2023 | Visumax |
| Eyevance Pharmaceuticals LLC | $125.56 | 2022 | |
| Dompe US, INC. | $111.15 | 2022-2025 | Oxervate |
| Amgen INC. | $104.41 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $87.13 | 2024-2025 | Xdemvy |
| Ocular Therapeutix, INC. | $86.03 | 2019 | |
| Harrow Eye, LLC | $66.67 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $45.64 | 2024-2025 | Acthar |
| Optos, INC. | $44.52 | 2021 | |
| Biotissue Holdings INC. | $34.32 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $33.43 | 2023 | Acuvue |
| Nova Eye, INC. | $21.94 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $18.23 | 2022 | |
| Lkc Technologies, INC. | $15.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$183.69 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.